Well Referenced

Tag: anxiety disorders

Virtual reality in the assessment, understanding, and treatment of mental health disorders

This systematic review analyzed 285 studies on the use of virtual reality (VR) in mental health, encompassing assessment (86 studies), theory development (45), and treatment (154). The predominant focus was on anxiety disorders (192 studies), followed by schizophrenia (44), substance-related disorders (22), and eating disorders (18). VR exposure-based treatments demonstrated

Read More »
June 26, 2025 No Comments

Preventing the return of fear using reconsolidation updating and methylene blue is differentially dependent on extinction learning

This animal study explored how reconsolidation updating, a behavioral technique, and methylene blue (MB), a metabolic enhancer, could prevent the return of conditioned fear responses in rats. Reconsolidation updating broadly reduced fear reinstatement, while MB was effective specifically in rats responsive to extinction learning. These findings suggest potential clinical strategies

Read More »
June 26, 2025 No Comments

Extinction memory improvement by the metabolic enhancer methylene blue

This animal study examined the effects of methylene blue (MB), a metabolic enhancer, on extinction memory retention in rats. Results showed that MB-treated rats exhibited significantly lower freezing behavior in response to the conditioned stimulus, indicating improved retention of extinction memory. Additionally, MB increased brain cytochrome oxidase activity by 38%,

Read More »
June 26, 2025 No Comments

Testosterone prescribing in men with depression and anxiety disorders

This observational study examined national trends in testosterone replacement therapy (TRT) prescribing among men aged 40-65 with depression and/or anxiety disorders in the U.S. from 2002 to 2016. TRT prescribing increased by 200% from 2002 to 2013 but declined by over 50% from 2013 to 2016. Notably, more than 20%

Read More »
June 26, 2025 No Comments